Illinois Municipal Retirement Fund Increases Stake in Astrana Health, Inc. (NASDAQ:ASTH)

Illinois Municipal Retirement Fund grew its position in Astrana Health, Inc. (NASDAQ:ASTH) by 16.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 24,987 shares of the company’s stock after buying an additional 3,593 shares during the period. Illinois Municipal Retirement Fund’s holdings in Astrana Health were worth $788,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Nisa Investment Advisors LLC bought a new stake in shares of Astrana Health during the third quarter valued at approximately $35,000. KBC Group NV bought a new stake in shares of Astrana Health in the 3rd quarter worth $70,000. Quarry LP purchased a new position in shares of Astrana Health in the third quarter worth $77,000. Quest Partners LLC purchased a new position in shares of Astrana Health in the third quarter worth $133,000. Finally, Paloma Partners Management Co bought a new position in shares of Astrana Health during the third quarter valued at $220,000. Institutional investors own 52.77% of the company’s stock.

Astrana Health Stock Performance

Shares of NASDAQ ASTH opened at $26.48 on Tuesday. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a 12-month low of $23.12 and a 12-month high of $63.20. The firm has a market capitalization of $1.49 billion, a price-to-earnings ratio of 20.37, a price-to-earnings-growth ratio of 1.37 and a beta of 1.20. The firm has a 50 day moving average of $34.84 and a 200 day moving average of $44.46.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. On average, research analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have weighed in on ASTH. Stifel Nicolaus decreased their target price on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research report on Thursday, February 20th. Robert W. Baird decreased their price objective on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a report on Monday. Macquarie upgraded shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Finally, Truist Financial decreased their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, January 13th. Two research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Astrana Health currently has a consensus rating of “Moderate Buy” and an average target price of $58.40.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.